GH1 and Creutzfeldt Jacob disease: The presence of Aβ in patients with iatrogenic CJD did not correlate with their length of growth hormone treatment nor their age at death, however, in human growth hormone recipients who did not develop iatrogenic CJD, being positive for Aβ was moderately correlated with earlier and longer duration of treatment with human growth hormone.